Elisabet García Rodríguez
Elisabet García, after qualifying as a Specialist Laboratory Technician, was initially employed in the Department of Biochemistry in the Hospital Clínic de Barcelona. Since joining IrsiCaixa, she has worked in Sample Processing and Sequencing and in the Cell Immunology and Virology group. She currently works with Tissue Virology group.
Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers.
Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy.
Gp120/CD4 blocking antibodies are frequently elicited in ART-naïve chronically HIV-1 infected individuals.
HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells.
Functional analyses reveal extensive RRE plasticity in primary HIV-1 sequences selected under selective pressure.